• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Orally administered liposomal formulations for colon targeted drug delivery.

作者信息

Hua Susan

机构信息

School of Biomedical Sciences and Pharmacy, The University of Newcastle Callaghan, NSW, Australia.

出版信息

Front Pharmacol. 2014 Jun 10;5:138. doi: 10.3389/fphar.2014.00138. eCollection 2014.

DOI:10.3389/fphar.2014.00138
PMID:24959147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4050429/
Abstract
摘要

相似文献

1
Orally administered liposomal formulations for colon targeted drug delivery.用于结肠靶向给药的口服脂质体制剂。
Front Pharmacol. 2014 Jun 10;5:138. doi: 10.3389/fphar.2014.00138. eCollection 2014.
2
Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.炎症性肠病药物的脂质体制剂：大鼠模型中的局部与全身给药
Pharm Res. 2005 Aug;22(8):1320-30. doi: 10.1007/s11095-005-5376-3. Epub 2005 Aug 3.
3
Oral Nano-Delivery Systems for Colon Targeting Therapy.用于结肠靶向治疗的口服纳米给药系统。
Pharm Nanotechnol. 2017;5(2):83-94. doi: 10.2174/2211738505666170424122722.
4
Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.用于炎症性肠病治疗中靶向给药的可生物降解纳米颗粒。
J Pharmacol Exp Ther. 2001 Nov;299(2):775-81.
5
Design and development of liposomes for colon targeted drug delivery.脂质体用于结肠靶向药物递送的设计与开发。
J Drug Target. 2013 Feb;21(2):146-60. doi: 10.3109/1061186X.2012.734311.
6
Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model.基于纳米复合材料的靶向口服药物传递系统，在溃疡性结肠炎模型中使用英夫利昔单抗。
J Nanobiotechnology. 2020 Sep 15;18(1):133. doi: 10.1186/s12951-020-00693-4.
7
Alpha-MSH Targeted Liposomal Nanoparticle for Imaging in Inflammatory Bowel Disease (IBD).用于炎症性肠病（IBD）成像的α-促黑素靶向脂质体纳米颗粒。
Curr Pharm Des. 2020;26(31):3840-3846. doi: 10.2174/1381612826666200727002716.
8
Liposomal nanostructures for photosensitizer delivery.用于递送光敏剂的脂质体纳米结构。
Lasers Surg Med. 2011 Sep;43(7):734-48. doi: 10.1002/lsm.21101.
9
Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats.口服载叶酸靶向白藜芦醇纳米粒治疗大鼠炎症性肠病。
Life Sci. 2020 Dec 1;262:118555. doi: 10.1016/j.lfs.2020.118555. Epub 2020 Oct 6.
10
Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model.聚合物纳米载体靶向递送环孢素 A 可改善相关小鼠模型中炎症性肠病的治疗效果。
Eur J Pharm Biopharm. 2017 Oct;119:361-371. doi: 10.1016/j.ejpb.2017.07.004. Epub 2017 Jul 12.

引用本文的文献

1
Tumor microenvironment-responsive nanoformulations for breast cancer.用于乳腺癌的肿瘤微环境响应性纳米制剂
Discov Nano. 2024 Dec 21;19(1):212. doi: 10.1186/s11671-024-04122-5.
2
Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy.纳米蛋白酶体靶向嵌合体（Nano-PROTACs）在癌症治疗中的应用。
Int J Nanomedicine. 2024 Jun 12;19:5739-5761. doi: 10.2147/IJN.S448684. eCollection 2024.
3
Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives.响应型纳米系统在溃疡性结肠炎靶向治疗中的应用：现状与未来展望。
Drug Deliv. 2023 Dec;30(1):2219427. doi: 10.1080/10717544.2023.2219427.
4
Multiparticulate Systems of Meloxicam for Colonic Administration in Cancer or Autoimmune Diseases.用于癌症或自身免疫性疾病结肠给药的美洛昔康多微粒系统。
Pharmaceutics. 2022 Jul 20;14(7):1504. doi: 10.3390/pharmaceutics14071504.
5
Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer.植物来源的外泌体作为治疗炎症性肠病和结肠炎相关癌症的药物递送方法。
Pharmaceutics. 2022 Apr 8;14(4):822. doi: 10.3390/pharmaceutics14040822.
6
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles.改善PROTACs在癌症中作用的方法：可控递送纳米颗粒的研发
Front Cell Dev Biol. 2022 Feb 3;9:805336. doi: 10.3389/fcell.2021.805336. eCollection 2021.
7
Prospects of Curcumin Nanoformulations in Cancer Management.姜黄素纳米制剂在癌症管理中的应用前景。
Molecules. 2022 Jan 7;27(2):361. doi: 10.3390/molecules27020361.
8
Nanomedicine for increasing the oral bioavailability of cancer treatments.用于提高癌症治疗口服生物利用度的纳米医学。
J Nanobiotechnology. 2021 Oct 30;19(1):354. doi: 10.1186/s12951-021-01100-2.
9
Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies.用于治疗炎症性肠病的受体介导靶向给药系统：机遇与新策略
Acta Pharm Sin B. 2021 Sep;11(9):2798-2818. doi: 10.1016/j.apsb.2020.11.003. Epub 2020 Nov 7.
10
Advances in Thiopurine Drug Delivery: The Current State-of-the-Art.硫嘌呤药物递送的进展：最新技术现状。
Eur J Drug Metab Pharmacokinet. 2021 Nov;46(6):743-758. doi: 10.1007/s13318-021-00716-x. Epub 2021 Sep 6.

本文引用的文献

1
Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats.巯基化壳聚糖包被的脂质体增强了肽在大鼠体内的口服递送。
J Control Release. 2013 Dec 28;172(3):872-8. doi: 10.1016/j.jconrel.2013.10.011. Epub 2013 Oct 16.
2
Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation.通过甘油磷酸酯-壳聚糖微复合改善脂质体二甲双胍的口服生物利用度和药代动力学。
AAPS PharmSciTech. 2013 Jun;14(2):485-96. doi: 10.1208/s12249-013-9926-4. Epub 2013 Mar 8.
3
Design and development of liposomes for colon targeted drug delivery.脂质体用于结肠靶向药物递送的设计与开发。
J Drug Target. 2013 Feb;21(2):146-60. doi: 10.3109/1061186X.2012.734311.
4
Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice.ICAM-1 靶向抗体与纳米载体在小鼠胃肠道中的体内分布与内吞作用。
Int J Nanomedicine. 2012;7:4223-37. doi: 10.2147/IJN.S34105. Epub 2012 Aug 1.
5
Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.用于口服结肠给药的pH响应性微球包裹脂质体
Int J Biomater. 2012;2012:458712. doi: 10.1155/2012/458712. Epub 2012 Jun 27.
6
Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties.巯基化壳聚糖与预先形成的脂质体的化学偶联提高了粘膜粘附性能。
Int J Nanomedicine. 2012;7:2523-34. doi: 10.2147/IJN.S29980. Epub 2012 May 21.
7
Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.通过黏附性脂质体给药系统提高阿仑膦酸钠的口服生物利用度。
Eur J Pharm Sci. 2012 Aug 15;46(5):500-7. doi: 10.1016/j.ejps.2012.04.002. Epub 2012 Apr 13.
8
Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth.靶向肿瘤相关内皮细胞：抗 VEGFR2 免疫脂质体介导肿瘤血管破坏并抑制肿瘤生长。
Clin Cancer Res. 2012 Jan 15;18(2):454-64. doi: 10.1158/1078-0432.CCR-11-1102. Epub 2011 Nov 7.
9
Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa.促炎细胞因子增强肠上皮细胞转铁蛋白受体表达，作为将药物递送至炎症肠道黏膜的局部给药途径。
PLoS One. 2011;6(9):e24202. doi: 10.1371/journal.pone.0024202. Epub 2011 Sep 6.
10
Studies on pectin coating of liposomes for drug delivery.脂质体果胶涂层用于药物输送的研究。
Colloids Surf B Biointerfaces. 2011 Dec 1;88(2):664-73. doi: 10.1016/j.colsurfb.2011.07.058. Epub 2011 Aug 6.